Utilization Management
Prescription Drug Prior Authorization and Step Therapy Policies for Cascade Select Marketplace Business
Not all medications will be covered on the formulary. Non-formulary medications are subject to the Medical Necessity for Non-Formulary Medications policy. Please consult the formulary to verify coverage.
| Hereditary Angioedema - Takhzyro PA Policy | Policy |
| Homozygous Familial Hypercholesterolemia - Evkeeza PA Policy | Policy |
| Homozygous Familial Hypercholesterolemia - Juxtapid PA Policy | Policy |
| Human Immunodeficiency Virus - Cabenuva DQM Policy - Per Days | Policy |
| Human Immunodeficiency Virus - Cabenuva PA Policy | Policy |
| Human Immunodeficiency Virus - Rukobia PA Policy | Policy |
| Human Immunodeficiency Virus - Sunlenca PA Policy | Policy |
| Human Immunodeficiency Virus - Trogarzo PA Policy | Policy |
| Hyaluronic Acid Derivatives (Intraarticular) PA Policy | Policy |
| Hydrocortisone Acetate Suppository Step Therapy Policy | Policy |
| Hydroxy-Methylglutaryl-Coenzyme A Reductase Inhibitors DQM Policy - Per Rx | Policy |
| Hyperhidrosis - Qbrexza PA Policy | Policy |
| Hyperhidrosis - Sofdra PA Policy | Policy |
| Hyperlipidemia - Nexletol PA with Step Therapy Policy | Policy |
| Hyperlipidemia - Nexlizet PA Policy | Policy |
| Hyperlipidemia - Omega-3 Fatty Acid Products PA Policy | Policy |
| Hyperlipidemia - PCSK9 Inhibitors - Leqvio PA Policy | Policy |
| Hyperlipidemia - PCSK9 Inhibitors - Lerochol PA Policy | Policy |
| Hyperlipidemia - PCSK9 Inhibitors - Lipfendra PA Policy | Policy |
| Hyperlipidemia - PCSK9 Inhibitors - Praluent PA Policy | Policy |
| Hyperlipidemia - PCSK9 Inhibitors - Repatha PA Policy | Policy |
| Hypertension - Clonidine Patches DQM Policy - Per Days | Policy |
| Hypoactive Sexual Desire Disorder - Addyi PA Policy | Policy |
| Hypoactive Sexual Desire Disorder - Vyleesi PA Policy | Policy |
| Hypoparathyroidism - Yorvipath PA Policy | Policy |
| Immune Disorder - Joenja PA Policy | Policy |
| Immune Globulin - Atgam PA Policy | Policy |
| Immune Globulin - Intravenous PA Policy | Policy |
| Immune Globulin - Subcutaneous PA Policy | Policy |
| Immune Globulin – Cytogam PA Policy | Policy |
| Immunologicals - Adbry DQM Policy - Per Days | Policy |
| Immunologicals - Asthma PSM Policy | Policy |
| Immunologicals - Dupixent DQM Policy - Per Days | Policy |
| Immunologicals - Dupixent PA Policy | Policy |
| Immunologicals - Ebglyss DQM Policy - Per Days | Policy |
| Immunologicals - Exdensur PA Policy | Policy |
| Immunologicals - Fasenra DQM Policy - Per Days | Policy |
| Immunologicals - Fasenra PA Policy | Policy |
| Immunologicals - Nemluvio PA Policy | Policy |
| Immunologicals - Nucala DQM Policy - Per Days | Policy |
| Immunologicals - Tezspire PA Policy | Policy |
| Immunologicals - Xolair DQM Policy - Per Days | Policy |
| Immunologicals - Xolair PA Policy | Policy |
| Infectious Disease - Antiparasitics DQM Policy - Per Rx and Per Days | Policy |
| Infectious Disease - Impavido PA Policy | Policy |
| Infectious Disease - Ivermectin Tablets PA Policy | Policy |
| Infectious Disease - Livtencity DQM Policy - Per Days | Policy |
| Infectious Disease - Livtencity PA Policy | Policy |
| Infectious Disease - Pretomanid PA Policy | Policy |
| Infectious Disease - Prevymis DQM Policy - Per Rx and Per Days | Policy |
| Infectious Disease - Pyrimethamine PA Policy | Policy |
| Infectious Disease - Sirturo PA Policy | Policy |
| Infectious Disease - Vancomycin (Oral) DQM Policy - Per Rx | Policy |
| Infectious Disease - Xifaxan DQM Policy - Per Rx | Policy |
| Infertility - Follitropins, Clomiphene PSM policy | Policy |
| Infertility - Gonadotropin-Releasing Hormone Antagonists PSM Policy | Policy |
| Inflammatory Conditions - Adalimumab Products Care Value Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Adalimumab Products DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Adalimumab Products PSM Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Arcalyst DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Bimzelx DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Cibinqo PA Policy | Policy |
| Inflammatory Conditions - Cosentyx Subcutaneous DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Etanercept Products DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Ilaris DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Ilaris PA Policy | Policy |
| Inflammatory Conditions - Ilumya DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Kineret DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Leqselvi PA Policy | Policy |
| Inflammatory Conditions - Litfulo PA Policy | Policy |
| Inflammatory Conditions - Rinvoq DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Siliq DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Simponi Subcutaneous DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Spevigo Intravenous PA Policy | Policy |
| Inflammatory Conditions - Spevigo Subcutaneous PA Policy | Policy |
| Inflammatory Conditions - Taltz DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Tocilizumab Intravenous Products PA Policy | Policy |
| Inflammatory Conditions - Tocilizumab Subcutaneous Products PA Policy | Policy |
| Inflammatory Conditions - Tofacitinib Products Care Value Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Tofacitinib Products PSM Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Tremfya Subcutaneous DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Ustekinumab Subcutaneous DQM Policy - Per Days | Policy |
| Inflammatory Conditions - Ustekinumab Subcutaneous Products Care Value Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Ustekinumab Subcutaneous Products PSM Policy for High Performance Formulary | Policy |
| Inflammatory Conditions - Zymfentra DQM Policy - Per Days | Policy |
| Inpefa PA Policy | Policy |
| Interferon - Actimmune PA Policy | Policy |
| Interleukin-1 Blockers for Cryopyrin-Associated Periodic Syndromes PSM Policy | Policy |
| Iron Replacement – Ferumoxytol PA Policy | Policy |
| Iron Replacement – INFeD PA Policy | Policy |
| Iron Replacement – Injectafer PA Policy | Policy |
| Iron Replacement – Iron Sucrose PA Policy | Policy |
| Iron Replacement – Monoferric PA Policy | Policy |
| Iron Replacement – Sodium Ferric Gluconate PA Policy | Policy |
| Isotretinoin Step Therapy Policy | Policy |
| Kygevvi PA Policy | Policy |
| Levothyroxine Products Step Therapy Policy | Policy |
| Lidocaine Patch Products PA Policy | Policy |
| Lipodystrophy - Egrifta PA Policy | Policy |
| Lipodystrophy - Myalept PA Policy | Policy |